John Niblack retired in 2002 as Vice Chairman of Pfizer Inc., a $32 billion pharmaceutical
company that discovers, develops, manufactures, and markets leadi
ng prescription medicines for humans and animals and many of the world's best-known
consumer brands. As Vice Chairman, Dr. Niblack was responsible for Pfizer's Global
Research and Development Division and pharmaceutical Licensing and Development. As
an active scientist from 1967-1980, Niblack rose in the company through a succession
of positions in which he directed research into drugs for viral illnesses, cancer
and autoimmune disorders. In 1980 he was appointed director of research for the company's
US laboratories. In 1990, he was named president of Pfizer's Central Research Division
and in 1993 was promoted to executive VP of Pfizer Inc. He has a BS in chemistry from
OSU and a Ph.D. in biochemistry from the University of Illinois.